Investigation of the dynamics of Runx2 activation during induction of osteogenic differentiation
E. S. Gromova,
K. E. Azarkina,
D. A. Kostina,
D. A. Perepletchikova,
D. S. Smirnova,
A. B. Malashicheva https://doi.org/10.18705/2311-4495-2024-11-3-284-293
Abstract
Background. Despite the fact that Runx2 is a generally recognized marker and regulator of osteogenic differentiation, the mechanisms of its regulation, the dynamics of activation during osteogenic differentiation and the relationship with other genes and gene pathways associated with osteogenic differentiation remain unclear.
The aim is to analyze the dynamics of Runx2 activation and the effect of stable protein levels on differentiation processes.
Materials and methods. Lentiviral constructs of RUNX2 genetic isoforms were used in the work: RUNX2full (full-size gene), RUNX2delta (shortened sequence), RUNX2stop (with stop codon), a hairpin design on RUNX2 — shRUNX2 was also used to suppress its activity. The proteasome degradation inhibitor MG132 was used to maintain stable protein levels in cells. To analyze the dynamics of Runx2 activation, osteogenic differentiation was induced for different time periods. The results were analyzed by Western blotting, real-time PCR, and alizarin red staining.
Results. Stabilization of the Runx2 protein at 24 hours of induction of osteogenic differentiation contributes to its strengthening. Also, the level of Runx2 transcripts does not change, but target genes are activated.
Conclusion. During the initiation of osteogenic differentiation of gingival fibroblasts in vitro, Runx2 is regulated at both the transcriptional and post-transcriptional levels; accumulation of a small level of transcripts during induction of osteogenic differentiation and stabilization of the Runx2 protein seem to be critically important.
Supporting agencies: Research is supported by a grant from The Russian Science Foundation №23-15-00320.
About the Authors
E. S. Gromova
Institute of Cytology of the Russian Academy of Science
Russian Federation
Competing Interests:
Russian Federation
Ekaterina S. Gromova, Senior Research Laboratory Assistant at the Laboratory of Regenerative Biomedicine
Tikhoretsky Prospekt, 4, Saint Petersburg, 194064
Competing Interests:
The authors declare no conflict of interest.
K. E. Azarkina
Institute of Cytology of the Russian Academy of Science
Russian Federation
Competing Interests:
Russian Federation
Ksenia E. Azarkina, Senior Research Laboratory Assistant at the Laboratory of Regenerative Biomedicine
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest.
D. A. Kostina
Institute of Cytology of the Russian Academy of Science
Russian Federation
Competing Interests:
Russian Federation
Daria A. Kostina, Researcher at the Laboratory of Regenerative Biomedicine
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest.
D. A. Perepletchikova
Institute of Cytology of the Russian Academy of Science
Russian Federation
Competing Interests:
Russian Federation
Daria A. Perepletchikova, Junior Researcher at the Laboratory of Regenerative Biomedicine
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest.
D. S. Smirnova
Institute of Cytology of the Russian Academy of Science
Russian Federation
Competing Interests:
Russian Federation
Darya V. Smirnova, Junior Researcher at the Laboratory of Regenerative Biomedicine
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest.
A. B. Malashicheva
Institute of Cytology of the Russian Academy of Science
Russian Federation
Competing Interests:
Russian Federation
Anna B. Malashicheva, Doctor of Biological Sciences, Head of the Laboratory of Regenerative Biomedicine
Saint Petersburg
Competing Interests:
The authors declare no conflict of interest.
References
1. Xu J, Li Z, Hou Y, Fang W. Potential mechanisms underlying the Runx2 induced osteogenesis of bone marrow mesenchymal stem cells. Am J Transl Res. 2015 Dec 15;7(12):2527-35. PMID: 26885254; PMCID: PMC4731654.
2. Rutkovskiy A, Stensløkken KO, Vaage IJ. Osteoblast Differentiation at a Glance. Med Sci Monit Basic Res. 2016 Sep 26;22:95-106. doi: 10.12659/msmbr.901142. PMID: 27667570; PMCID: PMC5040224.
3. Ferreira LB, Gimba E, Vinagre J, Sobrinho-Simões M, Soares P. Molecular Aspects of Thyroid Calcification. Int J Mol Sci. 2020 Oct 19;21(20):7718. doi: 10.3390/ijms21207718. PMID: 33086487; PMCID: PMC7589718.
4. Toth Z, Ward A, Tang SY, McBride-Gagyi S. Sexual differences in bone porosity, osteocyte density, and extracellular matrix organization due to osteoblastic-specific Bmp2 deficiency in mice. Bone. 2021 Sep;150:116002. doi: 10.1016/j.bone.2021.116002. Epub 2021 May 8. PMID: 33971313; PMCID: PMC8217247.
5. Chen Y, Mehmood K, Chang YF, Tang Z, Li Y, Zhang H. The molecular mechanisms of glycosaminoglycan biosynthesis regulating chondrogenesis and endochondral ossification. Life Sci. 2023 Dec 15;335:122243. doi: 10.1016/j.lfs.2023.122243. Epub 2023 Nov 8. PMID: 37949211.
6. Mevel R, Draper JE, Lie-A-Ling M, Kouskoff V, Lacaud G. RUNX transcription factors: orchestrators of development. Development. 2019 Sep 5;146(17):dev148296. doi: 10.1242/dev.148296. PMID: 31488508.
7. Lobov A, Kuchur P, Khizhina A, Kotova A, Ivashkin A, Kostina D, Klausen P, Khokhlova E, Repkin E, Postnikova K, Perepletchikova D, Denisov E, Gerashchenko T, Tikhilov R, Bozhkova S, Sereda A, Karelkin V, Enukashvily N, Malashicheva A. Mesenchymal Cells Retain the Specificity of Embryonal Origin During Osteogenic Differentiation. Stem Cells. 2024 Jan 13;42(1):76-89. doi: 10.1093/stmcls/sxad081. PMID: 37931142.
8. Stein GS, Lian JB, van Wijnen AJ, Stein JL, Montecino M, Javed A, Zaidi SK, Young DW, Choi JY, Pockwinse SM. Runx2 control of organization, assembly and activity of the regulatory machinery for skeletal gene expression. Oncogene. 2004 May 24;23(24):4315-29. doi: 10.1038/sj.onc.1207676. PMID: 15156188.
9. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G. Osf2/Cbfa1: a transcriptional activator of osteoblast differentiation. Cell. 1997 May 30;89(5):747-54. doi: 10.1016/s0092-8674(00)80257-3. PMID: 9182762.
10. Bruderer M, Richards RG, Alini M, Stoddart MJ. Role and regulation of RUNX2 in osteogenesis. Eur Cell Mater. 2014 Oct 23;28:269-86. doi: 10.22203/ecm.v028a19. PMID: 25340806.
11. Sudhakar S, Katz MS, Elango N. Analysis of type-I and type-II RUNX2 protein expression in osteoblasts. Biochem Biophys Res Commun. 2001 Aug 10;286(1):74-9. doi: 10.1006/bbrc.2001.5363. PMID: 11485310.
12. Uyama M, Sato MM, Kawanami M, Tamura M. Regulation of osteoblastic differentiation by the proteasome inhibitor bortezomib. Genes Cells. 2012 Jul;17(7):548-58. doi: 10.1111/j.1365-2443.2012.01611.x. Epub 2012 Jun 15. PMID: 22702336.
Review
For citations:
Gromova E.S., Azarkina K.E., Kostina D.A., Perepletchikova D.A., Smirnova D.S., Malashicheva A.B. Investigation of the dynamics of Runx2 activation during induction of osteogenic differentiation. Translational Medicine. 2024;11(3):284-293. (In Russ.) https://doi.org/10.18705/2311-4495-2024-11-3-284-293
Views:
185
Email this article 